Science Explorer Interactive view Map

ProLynx (United States)

Research works
30
▲ 10% vs 2013–17
Citations
1.3k
43.9 per fractional work
Top-10% rate
20.2%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: ProLynx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.47× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 9.23× its world share, 1 worksImmunology and Micro…Neuroscience: 1.39× its world share, 0 worksNeuroscienceChemistry: 0.41× its world share, 0 worksChemistryEngineering: 0.10× its world share, 0 worksEngineeringMaterials Science: 3.00× its world share, 1 worksMaterials ScienceMedicine: 2.70× its world share, 4 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 9.2×. Every wedge is a field page.

Who are the top researchers at ProLynx (United States)?

Ranked on the composite score, Gary W. Ashley lead among researchers whose main affiliation is ProLynx (United States).

  1. 1 Gary W. Ashley United States · #994,686 worldwide 90 citations · 34 works
All ranked researchers at ProLynx (United States)

Which keywords describe research at ProLynx (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Drug Delivery, Biomedical Applications, Tissue Engineering, Drug Discovery, Cancer Therapy, Cell Culture, Hydrogels and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Drug Delivery4▲ 28×4 topics
  2. Biomedical Applications4▲ 12×6 topics
  3. Tissue Engineering4▲ 22×4 topics
  4. Drug Discovery3▲ 27×5 topics
  5. Cancer Therapy3▲ 15×6 topics
  6. Cell Culture3▲ 80×2 topics
  7. Hydrogels3▲ 65×2 topics
  8. Immunotherapy2▲ 10×8 topics
  9. Nanoparticles2▲ 5.1×4 topics
  10. Chemotherapy2▲ 8.8×5 topics
  11. Heart Failure2▲ 14×3 topics
  12. Biomaterials2▲ 30×2 topics
  13. Cardiovascular Disease2▲ 4.6×3 topics
  14. Scaffold Design2▲ 199×1 topic
  15. Stimuli-Responsive Polymers2▲ 199×1 topic
  16. Clinical Trials1▲ 7.3×4 topics
  17. Glycemic Control1▲ 33×3 topics
  18. Insulin Therapy1▲ 41×3 topics
  19. Biomarkers1▲ 6.7×5 topics
  20. Click Chemistry1▲ 56×2 topics
  21. Epidemiology1◆ 1.09×3 topics
  22. Targeted Therapy1▲ 19×3 topics
  23. Chitosan1▲ 71×1 topic
  24. Foldamers1▲ 48×1 topic
  25. Homologous Recombination1▲ 60×2 topics
  26. Mucosal1▲ 140×1 topic
  27. Peptide Synthesis1▲ 48×1 topic
  28. Bioprinting1▲ 83×1 topic
  29. Cancer1▲ 2.6×5 topics
  30. Diagnosis1▲ 3.6×1 topic
  31. Glycosylation1▲ 16×2 topics
  32. Guidelines1▲ 7.7×1 topic
  33. Metastasis1▲ 11×3 topics
  34. Microfluidic Devices1▲ 46×1 topic
  35. Assembly Planning1▲ 40×1 topic
  36. Bioorthogonal Chemistry1▲ 101×1 topic
  37. Copper-Catalyzed Cycloaddition1▲ 101×1 topic
  38. Design for Manufacture1▲ 40×1 topic

Which research topics does ProLynx (United States) publish most on?

By volume in 2022–2025: Heart Failure Treatment and Management, Nanoparticle-Based Drug Delivery, PARP inhibition in cancer therapy and Connective tissue disorders research.

  1. 1 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
  2. 2 Nanoparticle-Based Drug Delivery Biomaterials 1 works
  3. 3 PARP inhibition in cancer therapy Oncology 0 works
  4. 4 Connective tissue disorders research Genetics 0 works
  5. 5 Toxin Mechanisms and Immunotoxins Immunology 0 works
  6. 6 DNA Repair Mechanisms Molecular Biology 0 works
  7. 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  8. 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  9. 9 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.1%not open45.9%

World: 28% of research is openly available.

with international co-authors16.6%domestic only83.4%

World: 19% is written across borders.

How has ProLynx (United States)'s research output changed?

Output in 2018–2022 was 10% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.